» FXIII Immunodepleted Deficient Human Plasma

RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS

FXIII Immunodepleted Deficient Human Plasma

Fresh Frozen Plasmas

Plasma deficient for Factor XIII assay.

Plasma frozen, immunodepleted, poor in platelets and certified to have less than 1% in FXIII.
It is deficient in both antigenic and functional assay.

Reference	Presentation	Packaging
6-FDPFXIII	Bottle	1 x 100 mL
6-FDPFXIII-10	Kit	10 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

FXIII (FXIII) or fibrin stabilization factor is the zymogen of a transglutaminase. FXIII is activated by thrombin, it intervenes in the final phase of fibrinoformation to stabilize the fibrin clot. It is also involved in the phenomena of tissue repair and scarring by allowing the association of collagen and fibronectin.
There are constitutional deficits in FXIII which are autosomal recessive inheritance. The severe forms are associated with a hemorrhagic syndrome. Acquired FXIII deficiency due to anti-FXIII autoantibodies is also a very important cause of bleeding diathesis.
The consumption of FXIII in various diseases (malignant infections, Crohn's disease, Henoch-Schoenlein purpura, major surgery, ...) usually results from a moderate drop in the level of FXIII.

Packaging in plastic cryotubes or in bottles of at least 100 mL.

Frozen, immuno-depleted plasmas are certified to have less than 1% for the element considered, both for the antigenic and functional assay in haemostasis. This box is intended for research use.

- No bovine additives
- No reconstitution error
- No plasma alteration linked to freeze-drying
- Cryotubes ready to use after thawing (4 min at 37°C).

- 10 cryotubes x 1 mL or 100 mL vial of frozen plasma.

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer.
	Distributor.

RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS

FXIII Immunodepleted Deficient Human Plasma

Fresh Frozen Plasmas

Price list, safety data sheets and notices are accessible to our registered customers.

Cryopep Catalogue
Thrombosis Haemostasis 2023

Cryopep Catalogue
Haemostasis Research 2023

Cryopep DEFICIENT PLASMAS

Product sheet FXIII Immunodepleted Deficient Human Plasma

You must identify yourself to search for a certificate of analysis

FXIII Immunodepleted Deficient Human Plasma

Fresh Frozen Plasmas

Product sheet

Price list, safety data sheets and notices are accessible to our registered customers.